Dr Kylie Morphett
Dr Kylie Morphett is a member of the Collaboration for Enhanced Research Impact (CERI) Coordinating Group, representing the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame.
Dr Morphett completed her PhD in November 2016 and has since worked as a Research Fellow at the University of Queensland School of Public Health. Prior to beginning her PhD, she worked in a number of nonprofit health-related roles, including as a Research Officer at the Cancer Council Queensland Viertel Cancer Research Centre, and as Project Officer at Active Ageing Australia, where she developed health promotion materials aimed at older adults. Her PhD research investigated how smokers understand the neuroscience of nicotine addiction and how this influences their sense of self-efficacy and choice of cessation methods. It also explored barriers to the use of best practice smoking cessation pharmacotherapies. Dr Morphett’s current research is focused on health communication related to tobacco and nicotine products, as well as emerging environmental contaminants.